» Articles » PMID: 38515944

Milk Fat Globule Epidermal Growth Factor 8 Alleviates Liver Injury in Severe Acute Pancreatitis by Restoring Autophagy Flux and Inhibiting Ferroptosis in Hepatocytes

Overview
Specialty Gastroenterology
Date 2024 Mar 22
PMID 38515944
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Liver injury is common in severe acute pancreatitis (SAP). Excessive autophagy often leads to an imbalance of homeostasis in hepatocytes, which induces lipid peroxidation and mitochondrial iron deposition and ultimately leads to ferroptosis. Our previous study found that milk fat globule epidermal growth factor 8 (MFG-E8) alleviates acinar cell damage during SAP binding to αvβ3/5 integrins. MFG-E8 also seems to mitigate pancreatic fibrosis inhibiting chaperone-mediated autophagy.

Aim: To speculate whether MFG-E8 could also alleviate SAP induced liver injury by restoring the abnormal autophagy flux.

Methods: SAP was induced in mice by 2 hly intraperitoneal injections of 4.0 g/kg L-arginine or 7 hly injections of 50 μg/kg cerulein plus lipopolysaccharide. -knockout mice were used to study the effect of MFG-E8 deficiency on SAP-induced liver injury. Cilengitide, a specific αvβ3/5 integrin inhibitor, was used to investigate the possible mechanism of MFG-E8.

Results: The results showed that MFG-E8 deficiency aggravated SAP-induced liver injury in mice, enhanced autophagy flux in hepatocyte, and worsened the degree of ferroptosis. Exogenous MFG-E8 reduced SAP-induced liver injury in a dose-dependent manner. Mechanistically, MFG-E8 mitigated excessive autophagy and inhibited ferroptosis in liver cells. Cilengitide abolished MFG-E8's beneficial effects in SAP-induced liver injury.

Conclusion: MFG-E8 acts as an endogenous protective mediator in SAP-induced liver injury. MFG-E8 alleviates the excessive autophagy and inhibits ferroptosis in hepatocytes by binding to integrin αVβ3/5.

Citing Articles

The role of autophagy in pancreatic diseases.

Zhang W, Wu Q, Shao B Front Pharmacol. 2024; 15:1444657.

PMID: 39403146 PMC: 11471688. DOI: 10.3389/fphar.2024.1444657.

References
1.
Capelletti M, Manceau H, Puy H, Peoch K . Ferroptosis in Liver Diseases: An Overview. Int J Mol Sci. 2020; 21(14). PMC: 7404091. DOI: 10.3390/ijms21144908. View

2.
Lankisch P, Apte M, Banks P . Acute pancreatitis. Lancet. 2015; 386(9988):85-96. DOI: 10.1016/S0140-6736(14)60649-8. View

3.
Jiang X, Stockwell B, Conrad M . Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021; 22(4):266-282. PMC: 8142022. DOI: 10.1038/s41580-020-00324-8. View

4.
Liu Z, Ma C, Wang Q, Yang H, Lu Z, Bi T . Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma. Biochem Biophys Res Commun. 2021; 589:247-253. DOI: 10.1016/j.bbrc.2021.12.019. View

5.
Tang D, Chen X, Kang R, Kroemer G . Ferroptosis: molecular mechanisms and health implications. Cell Res. 2020; 31(2):107-125. PMC: 8026611. DOI: 10.1038/s41422-020-00441-1. View